Millennium Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Millennium Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-50,000	Closed	-$366K	–	7486
2021 Q1	$366K	Buy	+50,000	New	+$431K	﹤0.01%	5083
2018 Q2	–	Sell	-1,990	Closed	-$58K	–	4375
2018 Q1	$58K	Hold	1,990	–	–	﹤0.01%	3528
2017 Q4	$56K	Buy	+1,990	New	+$61.8K	﹤0.01%	3715

Millennium Management's AVEO Position: Q1 2023 in Review

Millennium Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 49,299 shares — an estimated $737K sold.

Millennium Management first reported a position in AVEO in Q2 2013 and held it in 27 quarters. The position peaked at $12.1M in Q1 2018. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Millennium Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Millennium Management sold 49,299 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $737K.
Millennium Management first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 27 quarters.
Millennium Management's AVEO Pharmaceuticals, Inc. position peaked at $12.1M in Q1 2018.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.